Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Attassi
Predictors of Long-Term Outcome in Patients With Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy With 177Lu-Octreotate
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Related publications
DNA Damage in Blood Lymphocytes in Patients After 177Lu Peptide Receptor Radionuclide Therapy
European Journal of Nuclear Medicine and Molecular Imaging
Medicine
Nuclear Medicine
Radiology
Imaging
Joint Guidance on Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Neoadjuvant Treatment of Nonfunctioning Pancreatic Neuroendocrine Tumors With [177Lu-DOTA0,Tyr3]Octreotate
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
68Ga-Dotatate PET/CT for the Early Prediction of Response to Somatostatin Receptor-Mediated Radionuclide Therapy in Patients With Well-Differentiated Neuroendocrine Tumors
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Peptide Receptor Radionuclide Therapy in Patients With Medullary Thyroid Carcinoma: Predictors and Pitfalls
BMC Cancer
Cancer Research
Oncology
Genetics
Catecholamine Production in Patients With Gastroenteropancreatic Neuroendocrine Tumors
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Pitfalls in the Response Evaluation After Peptide Receptor Radionuclide Therapy With [ 177 Lu-Dota 0 ,Tyr 3 ]Octreotate
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Identification of Primary Tumors in Patients Presenting With Metastatic Gastroenteropancreatic Neuroendocrine Tumors
Surgery
Surgery
Nephrotoxicity After PRRT With 177Lu-Dota-Octreotate
European Journal of Nuclear Medicine and Molecular Imaging
Medicine
Nuclear Medicine
Radiology
Imaging
